Comment on: Ranibizumab and aflibercept intravitreal injection for treatment na ïve and refractory macular oedema in branch retinal vein occlusion.

Comment on: Ranibizumab and aflibercept intravitreal injection for treatment naïve and refractory macular oedema in branch retinal vein occlusion. Eur J Ophthalmol. 2020 Jul 24;:1120672120945103 Authors: Elkazza SA, Hogg HJ, Di Simplicio S, Dlay SS PMID: 32703021 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32703021?dopt=Abstract

Source: European Journal of Ophthalmology - July 23, 2020 Category: Opthalmology Authors: Elkazza SA, Hogg HJ, Di Simplicio S, Dlay SS Tags: Eur J Ophthalmol Source Type: research

More News: Lucentis | Opthalmology | Ranibizumab Injection | Vitamin A